verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: micro labs limited
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler micro labs limited
Dosage Form INJECTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Micro Labs Limited

Identifiers & Regulatory

Product NDC 42571-313
Product ID 42571-313_874186a5-c314-9d21-e053-2995a90ae376
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA211370
Listing Expiration 2026-12-31
Marketing Start 2019-03-04

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42571313
Hyphenated Format 42571-313

Supplemental Identifiers

RxCUI
1665057 1665061
UPC
0342571313753 0342571313869
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA211370 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (42571-313-75) / 2 mL in 1 VIAL
  • 1 VIAL in 1 CARTON (42571-313-86) / 4 mL in 1 VIAL
  • 25 VIAL in 1 CARTON (42571-313-87) / 2 mL in 1 VIAL
  • 5 VIAL in 1 CARTON (42571-313-96) / 4 mL in 1 VIAL
  • 5 VIAL in 1 CARTON (42571-313-97) / 2 mL in 1 VIAL
source: ndc

Packages (5)

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "874186a5-c314-9d21-e053-2995a90ae376", "openfda": {"upc": ["0342571313753", "0342571313869"], "unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["9c89764e-ff07-4077-a40f-91eb1c179af2"], "manufacturer_name": ["Micro Labs Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (42571-313-75)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-75", "marketing_start_date": "20190304"}, {"sample": false, "description": "1 VIAL in 1 CARTON (42571-313-86)  / 4 mL in 1 VIAL", "package_ndc": "42571-313-86", "marketing_start_date": "20190304"}, {"sample": false, "description": "25 VIAL in 1 CARTON (42571-313-87)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-87", "marketing_start_date": "20190424"}, {"sample": false, "description": "5 VIAL in 1 CARTON (42571-313-96)  / 4 mL in 1 VIAL", "package_ndc": "42571-313-96", "marketing_start_date": "20190424"}, {"sample": false, "description": "5 VIAL in 1 CARTON (42571-313-97)  / 2 mL in 1 VIAL", "package_ndc": "42571-313-97", "marketing_start_date": "20190424"}], "brand_name": "Verapamil Hydrochloride", "product_id": "42571-313_874186a5-c314-9d21-e053-2995a90ae376", "dosage_form": "INJECTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "42571-313", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Micro Labs Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA211370", "marketing_category": "ANDA", "marketing_start_date": "20190304", "listing_expiration_date": "20261231"}